Jushi Holdings (JUSHF) Interest Expenses (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Interest Expenses came in at $12.2 million in Q1 2026, up 20.82% year-on-year from $10.1 million in Q1 2025, and up 16.81% on a QoQ basis from $10.5 million in Q4 2025.
Jushi Holdings (JUSHF) Interest Expenses (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Interest Expenses data on file, last reported at $12.2 million in Q1 2026.
- On a quarterly basis, Interest Expenses rose 20.82% year-over-year to $12.2 million in Q1 2026; TTM through Mar 2026 was $12.2 million, a 66.22% decrease from a year earlier, with the FY2025 full-year figure at $41.3 million, up 8.74% from the prior year.
- Interest Expenses for Q1 2026 stood at $12.2 million, up from $10.5 million in the prior quarter.
- Over the last five years, Interest Expenses for JUSHF reached as high as $25.9 million in Q4 2022 and fell as low as $7.2 million in Q4 2023.
- Historically, Interest Expenses has averaged $11.1 million across 5 years, with a median of $10.1 million in 2025.
- Across the five-year window, Interest Expenses surged 174.09% in 2022 and slumped 72.23% in 2023, its largest moves.
- Year by year, Interest Expenses stood at $25.9 million in 2022, then slumped by 72.23% to $7.2 million in 2023, then advanced by 0.67% to $7.3 million in 2024, then soared by 44.36% to $10.5 million in 2025, then grew by 16.81% to $12.2 million in 2026.
- Per Business Quant data, the three most recent Interest Expenses figures were $12.2 million in Q1 2026, $10.5 million in Q4 2025, and $11.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 944.51 Mn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 1.77 Bn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 1.21 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 590.20 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Jushi Holdings | 79.96 Mn | 40.26 Mn | 29.88 Mn | 12.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.23 Mn |
| Mar 31, 2026 | 12.23 Mn |
| Dec 31, 2025 | 10.47 Mn |
| Dec 31, 2025 | 10.47 Mn |
| Sep 30, 2025 | 11.20 Mn |
| Sep 30, 2025 | 11.20 Mn |
| Jun 30, 2025 | 13.57 Mn |
| Jun 30, 2025 | 13.57 Mn |
| Mar 31, 2025 | 10.12 Mn |
| Mar 31, 2025 | 10.12 Mn |
| Dec 31, 2024 | 7.25 Mn |
| Dec 31, 2024 | 7.25 Mn |
| Sep 30, 2024 | 9.51 Mn |
| Sep 30, 2024 | 9.51 Mn |
| Jun 30, 2024 | 9.32 Mn |
| Jun 30, 2024 | 9.32 Mn |
| Mar 31, 2024 | 9.65 Mn |
| Mar 31, 2024 | 9.65 Mn |
| Dec 31, 2023 | 7.20 Mn |
| Dec 31, 2023 | 7.20 Mn |